Team

David B. Singer
Limited Partner, Maverick Capital Ltd.

Mr. Singer is responsible for Maverick's Private Investments.  He joined Maverick in 2004 from Oscient Pharmaceutical Corporation, where he was Chairman of the Board.  Mr. Singer is a founder and former CEO of three biotech companies: Affymetrix, Inc., Corcept Therapeutics, Inc., and Genesoft Pharmaceuticals, Oscient's predecessor.  He began his career at Baxter International and worked at Goldman Sachs & Co.  Mr. Singer currently serves on the boards of several private companies. 

Mr. Singer received his B.A. from Yale University and his M.B.A. from Stanford University.  He was a Crown Fellow of the Aspen Institute, and is currently a Sterling Fellow of Yale University, on the Rand Corporation's Health Advisory Board and a director of College Track.